Cargando…
Strongyloides ratti: In Vitro and In Vivo Activity of Tribendimidine
BACKGROUND: Strongyloidiasis is a truly neglected tropical disease, but its public health significance is far from being negligible. At present, only a few drugs are available for the treatment and control of strongyloidiasis. METHODOLOGY/PRINCIPAL FINDINGS: We investigated the activity of tribendim...
Autores principales: | Keiser, Jennifer, Thiemann, Kai, Endriss, Yvette, Utzinger, Jürg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217669/ https://www.ncbi.nlm.nih.gov/pubmed/18235851 http://dx.doi.org/10.1371/journal.pntd.0000136 |
Ejemplares similares
-
Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis
por: Keiser, Jennifer, et al.
Publicado: (2021) -
Strongyloides ratti and S. venezuelensis – rodent models of Strongyloides infection
por: VINEY, MARK, et al.
Publicado: (2017) -
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota
por: Schneeberger, Pierre H.H., et al.
Publicado: (2018) -
Tribendimidine and Albendazole for Treating Soil-Transmitted Helminths, Strongyloides stercoralis and Taenia spp.: Open-Label Randomized Trial
por: Steinmann, Peter, et al.
Publicado: (2008) -
Immunological Responses Elicited by Different Infection Regimes with Strongyloides ratti
por: Paterson, Steve, et al.
Publicado: (2008)